MedTrace Logo

Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients

NCT04031456 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-12-24

No results posted yet for this study

Summary

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve patients' hormonal profile in patients presenting with POI.

Conditions

  • Menopause, Premature
  • Menopause Related Conditions
  • Menopausal Syndrome
  • Premature Ovarian Failure
  • Ovarian Failure, Premature

Interventions

BIOLOGICAL

Autologous Platelet Rich Plasma

Autologous PRP intra ovarian infusion

BIOLOGICAL

Placebo-Platelet Free Plasma

Autologous PFP intra ovarian infusion

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    collaborator OTHER

  • Genesis Athens Clinic

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-30
Primary Completion
2026-01-30
Completion
2026-07-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031456 on ClinicalTrials.gov